Doximity vs Solventum
Solventum reported revenue of $8.3 billion in fiscal 2025, 12.9 times Doximity's $645 million in fiscal 2026. Doximity's revenue grew 13.1% in its latest year, and Solventum's grew 0.9%. Doximity had an operating margin of 33.3%, against 26.2% at Solventum. Free cash flow was $326 million at Doximity and −$10 million at Solventum. Their fiscal years end in different months (March 31 and December 31), so the periods don't line up exactly.
Side by side
| Doximity | Solventum | |
|---|---|---|
| Latest fiscal year | FY2026, Mar 31, 2026 | FY2025, Dec 31, 2025 |
| Revenue | $645M | $8.3B |
| Revenue growth | 13.1% | 0.9% |
| Revenue growth a year, last 5 years | 25.5% | — |
| Gross margin | 89.1% | 53.5% |
| Operating margin | 33.3% | 26.2% |
| Net margin | 30.4% | 18.7% |
| Free cash flow | $326M | −$10M |
| Free cash flow margin | 50.6% | −0.1% |
| Return on capital | 91.3% | 20.4% |
| Net debt to EBITDA | −3.3x | 1.6x |
| Dividends and buybacks | $432M | $0M |
| Change in diluted share count | −1.1% | 0.9% |
| Last close | $33.08 | $85.81 |
| P/E at the last close | 38.9× | 10.5× |
| Insider trades, last 12 months | sold $2.1 million | bought $100,344, sold $0 |
| Piotroski F-score | 4 of 9 | 5 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
DoximitySolventum
Operating margin
Percent of revenue
DoximitySolventum
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
DoximitySolventum
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Doximity and Solventum pages.